RNXT
RenovoRx Inc
3월 13일 4:00 PM ET (한국 3/14 05:00)
$0.84
+0.03 ▲ +3.35%
🌙 3월 13일 6:22 PM ET (한국 3/14 07:22)
$0.87
+0.04 ▲ +4.42%
| Index | - | P/E | - | EPS (ttm) | -0.36 | Insider Own | 3.54% | Shs Outstand | 0.04B | Perf Week | 5.68% |
| Market Cap | 0.03B | Forward P/E | - | EPS next Y | 20.47% | Insider Trans | 6.05% | Shs Float | 0.04B | Perf Month | -13.91% |
| Enterprise Value | 0.02B | PEG | - | EPS next Q | -0.08 | Inst Own | 17.94% | Short Float | 1.23% | Perf Quarter | -14.52% |
| Income | -0.01B | P/S | 32.91 | EPS this Y | 20.63% | Inst Trans | -2.75% | Short Ratio | 1.69 | Perf Half Y | -32.65% |
| Sales | 0.00B | P/B | 3.79 | EPS next 5Y | 51.14% | ROA | -104.58% | Short Interest | 0.44M | Perf YTD | -0.6% |
| Book/sh | 0.22 | P/C | 3.05 | EPS past 3/5Y | 17.62% 2.24% | ROE | -146.61% | 52W High | -42.41% ($1.45) | Perf Year | -18.13% |
| Cash/sh | 0.27 | P/FCF | - | Sales past 3/5Y | - | ROIC | -135.23% | 52W Low | 19.2% ($0.70) | Perf 3Y | -77.85% |
| Dividend Est. | - | EV/EBITDA | - | EPS Y/Y TTM | 37.89% | Gross Margin | - | Volatility(W/M) | 6.26% 7.53% | Perf 5Y | - |
| Dividend TTM | - | EV/Sales | 22.38 | Sales Y/Y TTM | - | Oper. Margin | -1252.16% | ATR (14) | 0.07 | Perf 10Y | - |
| Dividend Ex-Date | - | Quick Ratio | 5.68 | EPS Q/Q | 19.78% | Profit Margin | -1196.66% | RSI (14) | 43.07 | Recom | 1 |
| Dividend Gr. 3/5Y | - | Current Ratio | 5.83 | Sales Q/Q | - | SMA20 | -4.46% ($0.88) | Beta | 1.35 | Target Price | $6.75 |
| Payout | - | Debt/Eq | 0.03 | Earnings | 11000000 | SMA50 | -11.6% ($0.95) | Rel Volume | 1.59 | Prev Close | $0.81 |
| Employees | 10 | LT Debt/Eq | 0.02 | EPS/Sales Surpr. | - -34.39% | SMA200 | -23.35% ($1.1) | Avg Volume(3M) | 0.26M | Price | $0.84 |
| IPO | 2021/8/26 | Option/Short | No/Yes | Trades | 685 | Volume | 409,057 | Change | 3.35% |
뉴스 로딩 중...